Lensar Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Lensar Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010907
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Lensar Inc (Lensar), a subsidiary of Alphaeon Corp is a medical device company that designs, develops and manufactures laser and advanced 3D imaging technology and devices for refractive cataract surgery. The company provides surgeon with superior femtosecond laser technology. It offers various technologies such as LENSAR laser system, augmented reality and smart corneal incisions. Lensar’s laser system fs 3D (LLS-fs 3D) is used during cataract surgery for removal of the crystalline lens. The company’s augmented reality, a reconstructed 3-D imaging, measurement and guidance system provides high-resolution ocular images in a single scan. It also provides practice support and clinical training services. Lensar is headquartered in Orlando, Florida, the US.

Lensar Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Lensar Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Lensar Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Lensar Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Lensar Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Lensar Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Lensar Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Lensar (LaserSoft Vision) Secures USD16 Million in Venture Funding 10
LensAR Raises USD8 Million in Venture Financing 11
LensAR Raises US$10 Million In Venture Financing 12
LensAR Raises US$17.4 Million In Venture Financing 13
LensAR Raises US$5 Million In Venture Financing 14
LensAR Raises US$24 Million In Series F Financing Round 15
LensAR Secures US$1.4 Million In Venture Financing 16
LensAR Secures US$5 Million In Venture Financing 17
LensAR Secures US$2 Million In Financing Round 18
Private Equity 19
LensAR Completes US$27 Million In Private Equity Financing 19
Acquisition 20
Alphaeon Acquires LENSAR for USD59 Million 20
Topcon Europe Medical Invests US$4 Million In LensAR 21
Lensar Inc – Key Competitors 22
Lensar Inc – Key Employees 23
Lensar Inc – Locations And Subsidiaries 24
Head Office 24
Recent Developments 25
Corporate Communications 25
Nov 08, 2017: Ophthalmic Industry Leader William J. Link, Ph.D., Joins LENSAR Board of Directors as Chairman 25
Legal and Regulatory 26
Dec 19, 2016: Lensar Strategic Restructure In Partnership With Pdl Biopharma
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Lensar Inc, Medical Equipment, Key Facts 2
Lensar Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Lensar Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Lensar Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Lensar Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Lensar Inc, Deals By Market, 2011 to YTD 2017 8
Lensar Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Lensar (LaserSoft Vision) Secures USD16 Million in Venture Funding 10
LensAR Raises USD8 Million in Venture Financing 11
LensAR Raises US$10 Million In Venture Financing 12
LensAR Raises US$17.4 Million In Venture Financing 13
LensAR Raises US$5 Million In Venture Financing 14
LensAR Raises US$24 Million In Series F Financing Round 15
LensAR Secures US$1.4 Million In Venture Financing 16
LensAR Secures US$5 Million In Venture Financing 17
LensAR Secures US$2 Million In Financing Round 18
LensAR Completes US$27 Million In Private Equity Financing 19
Alphaeon Acquires LENSAR for USD59 Million 20
Topcon Europe Medical Invests US$4 Million In LensAR 21
Lensar Inc, Key Competitors 22
Lensar Inc, Key Employees 23

★海外企業調査レポート[Lensar Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Playboy Enterprises Inc:企業の戦略的SWOT分析
    Playboy Enterprises Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Oswaldo Cruz Foundation-製薬・医療分野:企業M&A・提携分析
    Summary Oswaldo Cruz Foundation (Oswaldo Cruz) is a provider of research development, vaccines production, drugs, reagents and diagnostic kits. The foundation provides research in experimental models of disease, infectious agent vector biology, information and communication in health, management of …
  • Interleukin Genetics Inc (ILIU)-医療機器分野:企業M&A・提携分析
    Summary Interleukin Genetics Inc (Interleukin) is a molecular diagnostics company which develops and distributes genetic tests for the personalized health market. Its major genetic tests include ILUSTRA genetic risk test ; cardiovascular risk test; weight management genetic test; bone health genetic …
  • The Walsh Group:企業の戦略的SWOT分析
    The Walsh Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Elektroprivreda Crne Gore AD Niksic:電力:M&Aディール及び事業提携情報
    Summary Elektroprivreda Crne Gore AD Niksic (Elektroprivreda) is an electric utility service provider that generates, transmits, distributes, and supplies electricity to its consumers across Montenegro. The utility operates hydro and thermal power generation plants. It offers customer services such …
  • First Quantum Minerals Ltd:戦略・SWOT・企業財務分析
    First Quantum Minerals Ltd - Strategy, SWOT and Corporate Finance Report Summary First Quantum Minerals Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Aixtron SE (AIXA):企業の財務・戦略的SWOT分析
    Aixtron SE (AIXA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • GAIL (India) Limited:企業の戦略・SWOT・財務分析
    GAIL (India) Limited - Strategy, SWOT and Corporate Finance Report Summary GAIL (India) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • CiMaas BV:製薬・医療:M&Aディール及び事業提携情報
    Summary CiMaas BV (CiMaas) develops cellular immunotherapies (vaccines) for the treatment of cancer. Its pipeline cellular therapeutic products include CIM101, a dendritic cell vaccine being developed using its proprietary maturation technology for the treatment of lung cancer; and CIM201, a haploid …
  • Ambu AS (AMBU B):企業の財務・戦略的SWOT分析
    Ambu AS (AMBU B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • PPC Limited:企業の戦略・SWOT・財務情報
    PPC Limited - Strategy, SWOT and Corporate Finance Report Summary PPC Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Cap Gemini S.A.:戦略・SWOT・企業財務分析
    Cap Gemini S.A. - Strategy, SWOT and Corporate Finance Report Summary Cap Gemini S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Virometix AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Virometix AG (Virometix) is a biotechnology company that develops vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and chronic human diseases. The company’s pipeline products include prophylactic and therapeutic vaccines for infectious, respiratory, and onc …
  • Vanda Pharmaceuticals Inc (VNDA):製薬・医療:M&Aディール及び事業提携情報
    Summary Vanda Pharmaceuticals Inc (Vanda Pharmaceuticals) is a specialty pharmaceutical company that develops and commercializesnovel therapies for the treatment of central nervous system disorders. The company’s products include Hetlioz, a melatonin receptor agonist for the treatment of non-24-hour …
  • Hanesbrands Inc (HBI):企業の財務・戦略的SWOT分析
    Hanesbrands Inc (HBI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Orkla ASA:企業の戦略・SWOT・財務情報
    Orkla ASA - Strategy, SWOT and Corporate Finance Report Summary Orkla ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Page Industries Ltd:企業の戦略・SWOT・財務分析
    Page Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Page Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Jacobs Engineering Group Inc (J):企業の財務・戦略的SWOT分析
    Jacobs Engineering Group Inc (J) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • University of Michigan-製薬・医療分野:企業M&A・提携分析
    Summary University of Michigan (UM) is an educational service provider that offers educational and research services. The university offers graduate, undergraduate and post-doctoral levels programs in various disciplines. It operates various graduate schools and colleges of graduate studies, archite …
  • Nuvo Pharmaceuticals Inc (NRI):製薬・医療:M&Aディール及び事業提携情報
    Summary Nuvo Pharmaceuticals Inc (Nuvo), formerly Nuvo Research Inc, is a healthcare company that offers portfolio of commercial products and pharmaceutical manufacturing capabilities. The company’s product portfolio includes pennsaid, heated lidocaine and tetracaine patches. Its products deliver dr …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆